MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
This Quarter Return
-16.69%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$305M
AUM Growth
+$305M
(-12%)
Cap. Flow
+$18.2M
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
26.93%
Holding
118
New
12
Increased
35
Reduced
42
Closed
26
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$19M |
| 2 |
Chesapeake Utilities
CPK
|
$7.38M |
| 3 |
Merit Medical Systems
MMSI
|
$5.97M |
| 4 |
BCPC
Balchem Corporation
BCPC
|
$4.59M |
| 5 |
RBC Bearings
RBC
|
$3.73M |
Top Sells
| 1 |
Chord Energy
CHRD
|
$5.21M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$4.71M |
| 3 |
Ollie's Bargain Outlet
OLLI
|
$3.4M |
| 4 |
CareDx
CDNA
|
$3.39M |
| 5 |
8x8 Inc
EGHT
|
$2.43M |
Sector Composition
| 1 | Financials | 15.63% |
| 2 | Industrials | 13.45% |
| 3 | Healthcare | 13.09% |
| 4 | Technology | 10.85% |
| 5 | Consumer Discretionary | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
American Woodmark
AMWD
$922M
| – | – |
-27,389
| Closed | -$2.15M |
|
|
102
CareDx
CDNA
$678M
| – | – |
-117,526
| Closed | -$3.39M |
|
|
103
Chord Energy
CHRD
$6.12B
| – | – |
-367,166
| Closed | -$5.21M |
|
|
104
8x8 Inc
EGHT
$270M
| – | – |
-114,429
| Closed | -$2.43M |
|
105
East-West Bancorp
EWBC
$14.7B
| – | – |
-3,430
| Closed | -$207K |
|
106
Fate Therapeutics
FATE
$115M
| – | – |
-98,993
| Closed | -$1.61M |
|
107
FibroGen
FGEN
$48.4M
| – | – |
-33,822
| Closed | -$2.06M |
|
108
HEICO Class A
HEI.A
$34.9B
| – | – |
-3,046
| Closed | -$230K |
|
109
Hexcel
HXL
$5.08B
| – | – |
-3,259
| Closed | -$219K |
|
110
Madrigal Pharmaceuticals
MDGL
$9.7B
| – | – |
-10,467
| Closed | -$2.24M |
|
111
Neurocrine Biosciences
NBIX
$13.5B
| – | – |
-1,725
| Closed | -$212K |
|
112
NeoGenomics
NEO
$1.06B
| – | – |
-155,974
| Closed | -$2.39M |
|
|
113
Ollie's Bargain Outlet
OLLI
$7.89B
| – | – |
-35,351
| Closed | -$3.4M |
|
114
Pfizer
PFE
$141B
| – | – |
-4,646
| Closed | -$205K |
|
115
Target
TGT
$42B
| – | – |
-2,533
| Closed | -$223K |
|
116
TransUnion
TRU
$16.8B
| – | – |
-3,255
| Closed | -$240K |
|
117
UroGen Pharma
URGN
$896M
| – | – |
-18,200
| Closed | -$860K |
|
118
Western Alliance Bancorporation
WAL
$9.88B
| – | – |
-3,674
| Closed | -$209K |
|